[1]
Önal, B. et al. 2021. Tocilizumab Treatment Affects Intensive Care Unit Admission Rates of COVID-19 Patients in a Dose-dependent Manner. Cerrahpaşa Medical Journal. 45, 3 (Sep. 2021), 177–184. DOI:https://doi.org/10.5152/cjm.2021.21057.